Tag: Ridgeback Biotherapeutics LP

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ridgeback Biotherapeutics LP

Ridgeback Biotherapeutics LP Announces the Approval of EbangaTM for Ebola

Added to Collection on: 2020-12-22 15:11:15

Tags for this article:

Medical specialties
Infectious diseases
Virology
Biological weapons
Tropical diseases
Zoonoses
Animal virology
Ansuvimab
Jean-Jacques Muyembe-Tamfum
Ebola
Vaccine Research Center
Molnupiravir
Ridgeback Biotherapeutics LP
Miami

Click the tags to see associated articles and topics

View Article Details
Ebola Virus Treatment Ebanga Gets FDA Approval

Added to Collection on: 2020-12-22 15:45:00

Tags for this article:

Medical specialties
Ebola
Medicine
Clinical medicine
Tropical diseases
Biological weapons
Zoonoses
Monoclonal antibodies
Ansuvimab
Zaire ebolavirus
Ebola virus disease treatment research
REGN-EB3
Ridgeback Biotherapeutics LP

Click the tags to see associated articles and topics

View Article Details
Covid-19 pill shows promise in preliminary testing

Added to Collection on: 2021-03-06 07:18:45

Tags for this article:

Health sciences
Health
Medicine
Antiviral drugs
Gilead Sciences
Zoonoses
Molnupiravir
Medical research
Remdesivir
Coronavirus disease
COVID-19 vaccine
Oseltamivir
Ridgeback Biotherapeutics LP

Click the tags to see associated articles and topics

View Article Details
Merck's Covid-19 Pill Backed by FDA Advisers - WSJ

Added to Collection on: 2021-12-01 08:31:18

Tags for this article:

Health
Bayer AG
Kenilworth, New Jersey
Merck & Co.
Schering-Plough
Antiviral drug
Food and Drug Administration
Ridgeback Biotherapeutics LP

Click the tags to see associated articles and topics

View Article Details
What You Should Know About Treating Covid-19 - WSJ

Added to Collection on: 2021-12-02 19:21:12

Tags for this article:

Health sciences
Health care
Health
Antiviral drugs
COVID-19 drug development
COVID-19 vaccination in the United States
Clinical trials
Hydroxylamines
Molnupiravir
Merck & Co.
Ridgeback Biotherapeutics
Pfizer-BioNTech COVID-19 vaccine
Merck & Co .
United States
Ridgeback Biotherapeutics LP

Click the tags to see associated articles and topics

View Article Details
Merck and Ridgeback's Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment ...

Added to Collection on: 2021-12-24 15:52:50

Tags for this article:

Health sciences
Health
Antiviral drugs
COVID-19 drug development
Hydroxylamines
Molnupiravir
Pyrimidines
Ridgeback Biotherapeutics
Merck & Co.
Treatment and management of COVID-19
Medicines Patent Pool
SARS-CoV-2 Omicron variant
Kenilworth
Ridgeback Biotherapeutics LP
Canada
United Kingdom
Merck & Co Inc
United States
Miami

Click the tags to see associated articles and topics

View Article Details